AIM To determine whether patient triggered ventilation (PTV) leads to greater exposure to significant hypocarbia than conventional ventilation (CMV) in premature infants during the first 72 hours of life.
METHODS Infants of 32 weeks gestation or less were included. Randomisation yielded 74 infants on PTV and 68 infants on CMV. Arterial Paco 2measurements were taken four hourly for the first 72 hours of life.
RESULTS The mean Paco 2 levels on days 1, 2, and 3 were not significantly different between the two groups. The proportion of infants with Paco 2 levels of 3.33 kPa or less did not differ between PTV and CMV infants. Mean percentages of infants with this level of hypocarbia at any time were 31.4%, 18.9%, 8.8% on days 1, 2, and 3 respectively. Cumulative hypocarbia, below a 3.33 kPa threshold, was 0.0084 kPa.h (PTV) versus 0.0263 kPa.h (CMV) per hour ventilated during the first 24 hours (p = 0.259). Risk factors associated with hypocarbia on day 1 were peak inspiratory pressure below 14 cm H2O (odds ratio 4.79) as well as Fio 2 below 0.30 (odds ratio 3.42).
CONCLUSION Exposure to hypocarbia (Paco 2 3.33 kPa or below) was not significantly different between PTV and CMV infants during the first 72 hours of life. Hypocarbia was common in both groups on day 1 and to a lesser extent on day 2. Infants with the least requirements for ventilatory support were at highest risk of hypocarbia on day 1 of life. Preterm infants with mild hyaline membrane disease require a more aggressive approach to weaning on both modes of ventilation, followed by extubation to limit the risk of hypocarbia.
- patient triggered ventilation
- intermittent positive pressure ventilation
Statistics from Altmetric.com
Carbon dioxide is an important regulator of cerebral blood flow in the preterm infant.1 Wyatt et al found a reduction in cerebral blood flow to be associated with lower Paco 2 levels and showed greater cerebrovascular sensitivity to hypocarbia with increasing gestational age.2
Measures of significant hypocarbia have included one or more measurements of arterial CO2(Paco 2) below 20 mm Hg (2.67 kPa)5or 25 mm Hg (3.33 kPa),6 or a measure of the severity and duration of hypocarbia below a threshold of 25 mm Hg (3.33 kPa), cumulative hypocarbia (mm Hg.hours).7
Opinion in the literature is divided regarding the effect of trigger ventilation on arterial carbon dioxide tension. Two small studies11 12 conducted in the presurfactant and a third13 in the surfactant era showed significantly lower Pco 2 levels in infants switched over from conventional to trigger ventilation. A similar study reported greater tidal volumes in premature infants with respiratory distress syndrome (RDS) on patient triggered ventilation (PTV), but no significant reduction in carbon dioxide concentrations.14
The aim of this study was to establish whether PTV was associated with a greater risk of significant hypocarbia in premature infants. The trigger ventilation trial15 provided an opportunity to study this using routinely recorded arterial blood gas data.
Patients and methods
The study utilised all patients recruited by a single centre (Plymouth) within a multicentre trigger ventilation trial designed to compare PTV and conventional ventilation (CMV) in RDS. Infants less than 32 weeks gestation requiring ventilation within 72 hours of birth, with clinical and x ray features compatible with respiratory distress syndrome (RDS), were eligible for trial entry. Infants with evidence of major congenital malformations and inhalational pneumonitis were excluded.
The mode of ventilation was allocated by an independent nurse providing the telephone randomisation service, within six hours of commencing ventilation. Randomisation was performed in blocks of varying size. After randomisation four infants were changed from PTV to CMV: two because of failure to trigger, one because of failure to oxygenate, and one following a pulmonary haemorrhage. Analysis was performed on an intention to treat basis.
The SLE 2000 jet ventilator was used in either CMV or PTV mode. Prior to randomisation infants were ventilated with the attending clinician's preferred mode and technique of ventilation. After randomisation the ventilator was switched to the allocated mode and ventilation was guided by the following protocol: peak inspiratory pressure was adjusted according to chest wall movement and blood gas results and positive end expiratory pressure set at 4–5 cm H2O. In PTV mode an inspiratory time of 0.2–0.3 seconds was chosen initially, the ventilator set to trigger each inspiratory effort with a back up rate of 35 breaths per minute. The back up rate could be increased in apnoeic infants. Those receiving CMV had ventilator rates set either to the infant's spontaneous respiratory rate, or at 80 breaths per minute, with instructions to alter the rate as required. Initial inspiratory times were set at 0.34 seconds. Weaning was achieved by reducing inspiratory pressures to a minimum of 8–12 cm H2O on PTV and by reducing the inspiratory pressure to a minimum of 16 cm H2O followed by reducing the ventilator rate on CMV.
The attending clinicians were guided by the ventilation protocol and used clinical judgement to manage suboptimal blood gas results. The magnitude of change in ventilator settings was left to the judgement of individual doctors. The use of either caffeine or theophylline and morphine was permissible. All infants were eligible for surfactant in accordance with the unit's protocol.
BLOOD GAS ANALYSIS
Blood gas values were measured from samples obtained from indwelling arterial catheters every four hours, and within one hour following changes in ventilator settings. Measurements taken prior to randomisation were excluded from the analysis. Transcutaneous CO2 electrodes were not routinely used in the study infants in the first few postnatal days.
Paco 2 data analysis was performed retrospectively from intensive care charts. Cumulative hypocarbia for each infant was calculated using S-PLUS according to the method of Wiswell et al.7 Mean values were compared using Student's t test for parametric data and the Mann–Whitney test for non-parametric data. When comparing differences in proportions the χ2 test was used. Analysis of variance was used to compare the difference in the pre- and post-randomisation Paco 2 measurements in four groups of infants: those switched from CMV to PTV and PTV to CMV as well as those remaining on either CMV or PTV. Logistic regression was used to evaluate the effect of several postnatal variables on the risk of developing hypocarbia on day 1 of life. Risk was expressed as an odds ratio with 95% confidence limits. Goodness of fit was determined by the Hosmer–Lemeshow statistic in which a high p value indicates an adequate fit of the data to the model.
All statistical analyses were conducted on SPSS. We considered p < 0.05 statistically significant.
Written informed parental consent was sought prior to randomisation and local research ethics committee approval was obtained for the trigger ventilation trial. Blood gas estimations and all other management was delivered at the discretion of the clinicians within the research protocol outlined.
Randomisation yielded 74 infants on PTV and 68 infants on CMV. Infants were comparable at trial entry (table 1). Similar respiratory rates and fractions of inspired oxygen (Fio 2) were measured, but median peak inspiratory pressures (PIP) were lower in the PTV group on days 1 and 2 respectively (14.7v 16.9 cm H2O (p = 0.002) and 14.5 v 17.8 cm H2O (p = 0.008)).
The proportion of infants with one or more episodes of hypocarbia (Paco 2 3.33 kPa or below) was 34.7% (PTV)v 27.9% (CMV) on day 1, 18.6% (PTV)v 19.1% (CMV) on day 2, and 9.1% (PTV)v 8.5% (CMV) on day 3 (p > 0.05). Overall 37.3% of all infants experienced inadvertent hypocarbia during the first 72 hours.
The mean Paco 2 measured on day 1 was 4.8 kPa (PTV) v 5.19 kPa (CMV) (p = 0.05). Mean Paco 2 measurements on days 2 and 3 were 5.89 kPa (PTV) v 5.85 kPa (CMV) and 6.1 kPa (PTV)v 6.0 kPa (CMV) respectively (p > 0.05).
The median area below the 3.33 kPa threshold and above the CO2 curve (cumulative hypocarbia), was 0.0084 kPa.h (PTV)v 0.0263 kPa.h (CMV) per hour ventilated during the first 24 hours (p = 0.259).
Analysis of variance showed no significant difference in mean pre- and post-randomisation Paco 2 levels in four groups of infants: those switched over from CMV to PTV or from PTV to CMV as well as those remaining on their prerandomisation mode of ventilation, either CMV or PTV.
Using univariate analyses we evaluated several factors considered to play a potential role in the development of hypocarbia (Paco 2 3.33 kPa or below) on day 1 of life, including: mode of ventilation, gestation, weight, sex, antenatal steroids, use of surfactant, natural versus synthetic surfactant, peak inspiratory pressures, Fio 2, respiratory rate, and illness severity (CRIB score16). We used stepwise logistic regression to assess whether any of these factors were independent predictors of hypocarbia.
The only factors incurring significant risk were mean peak inspiratory pressures and mean Fio 2 on day 1. Both these factors had an inverse dose–response relationship with lower peak inspiratory pressures and Fio 2 being associated with a higher risk of hypocarbia. The association of PIP and Fio 2 with hypocarbia was not confounded by the other factors investigated. A multicolinear relation existed between Fio 2 and PIP, and therefore these variables were entered separately in the final model.
Infants ventilated with mean peak inspiratory pressures less than 14 cm H2O were 4.79 times as likely to develop hypocarbia as those with peak inspiratory pressures greater than 16 cm H2O. An Fio 2 of less than 0.3 incurred 3.4 times the risk of an Fio 2 of greater than 0.6 (table 2).
The mean arterial carbon dioxide tension during the first 72 hours was not significantly different between the two groups; a non-significant trend towards lower mean Paco 2levels was noted during PTV on day 1 (p = 0.05). No significant difference in cumulative hypocarbia was detected. The proportion of infants with Paco 2 levels of 3.33 kPa or below did not differ between PTV and CMV infants. Hypocarbia was a regular occurrence on day 1 during both modes of ventilation with 31.3% of all infants experiencing Paco 2 levels of 3.33 kPa or less. The risk factors associated with hypocarbia on day 1 were peak inspiratory pressures less than 14 cm H2O as well as inspired O2 concentrations less than 30%. PTV mode was not associated with an increased risk of hypocarbia in the regression model. Infants receiving minimal ventilation with mild lung disease on the first day of life were therefore more prone to hypocarbia.
We utilised data routinely collected by one centre within the multicentre trigger ventilation trial, which limited some of the analysis. Calculation of oxygenation indices was precluded as Pao 2 data were not available. Oxygenation indices would have provided a better marker for severity of lung disease than Fio 2 alone. Working within the design of the multicentre trigger ventilation trial provided two well matched groups with the exception of male gender. A larger proportion of male infants was randomised to the CMV group; however, the difference in proportions was not significant and male sex was not associated with hypocarbia in the regression model.
It is possible that the randomisation process selected infants with milder lung disease and consequently the large proportion of hypocarbic infants might be an overestimation of the problem. The two groups were well matched in terms of illness severity, both with median CRIB scores of 7, and the CRIB score did not feature as a significant variable in the regression model.
We considered whether inadvertent hypocarbia could have been an artefact of the ventilation protocol. Analysis of variance showed no significant difference between pre- and post-randomisation Paco 2 levels. Making the assumption that the pre-randomisation Paco 2 level reflects the attending clinician's chosen style of ventilation, we consider it unlikely that the guidance provided by the protocol was solely to blame for inadvertent hypocarbia.
Significant hypocarbia was defined as an arterial Pco 2 level less than or equal to 3.33 kPa (25 mm Hg), based on the findings of two other studies.6 7Calvert et al compared 15 preterm infants with periventricular leukomalacia (PVL) with 15 preterm controls without PVL and showed that infants with PVL had longer periods with Paco 2 readings below 3.33 kPa during the first 72 hours of life.6 Wiswell et al showed that cumulative hypocarbia below a threshold level of 3.33 kPa during the first day of life was the single factor independently related to the development of cystic PVL.7
Our infants on PTV received lower peak inspiratory pressures than infants on CMV during the first two days of life. The study of Hummleret al showed that infants on trigger ventilation required lower peak inspiratory pressures than those on intermittent mandatory ventilation to maintain a similar level of minute ventilation.13 The lower peak inspiratory pressures could be caused by a similar mechanism. Alternatively, this probably simply reflects the different weaning strategies, with lower peak inspiratory pressures before extubation in the PTV group.
The use of stepwise logistic regression identified those infants with the least requirements for ventilatory support as having the highest risk of hypocarbia, regardless of mode of ventilation. This suggests that a more aggressive approach to extubation and withdrawal of ventilation is required, particularly on day 1. Our literature search provided no evidence of similar studies investigating the risk factors associated with hypocarbia in preterm infants.
The frequency of inadvertent hypocarbia on day 1 was of concern. We were unable to find comparable information from other units. Exposure to inadvertent hypocarbia in ventilated preterm infants on day 1 could be used as a measure of the effectiveness of ventilator management, as part of an audit of practice.
In conclusion, hypocarbia is an undesirable and frequently encountered consequence of ventilation. Preterm infants with mild hyaline membrane disease require careful monitoring of Paco 2levels and timely weaning of ventilation to extubation to limit the risk of hypocarbia.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.